Product Code: BHP1187SA
“Global Gene Cloning Services Market to Reach $11,524.4 Million by 2031.”
Market Report Coverage - Gene Cloning Services
Market Segmentation
- Service (Gene Synthesis Service, Molecular Biology Service, Custom Cloning Service, and Other Service)
- Gene Type (Standard Gene, Complex Gene, and Other Gene Type)
- Application (Gene Synthesis, Gene Expression, Vaccine Research, Gene Therapy, and Other)
- End User (Academic and Research Institutions, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User)
Regional Segmentation
- North America: U.S. and Canada
- Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of- Europe
- Asia-Pacific: Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific
- Latin America: Brazil, Mexico, and Rest-of-Latin America
Market Growth Drivers
- Favorable Funding Scenario for Gene Synthesis and Cloning Services
- Technological Advancement in Cloning and Sub Cloning Services
- Rise in Synergistic Activities in Market
Market Challenges
- Complications Associated with Large-Scale Production of Cloning Vectors
- Lower Transfection Efficiency
Market Opportunities
- Rise in Demand for Gene and Cloning Services
- Limitation of Vectors or Plasmid
- Development of New Economical Technologies and Services
Key Companies Profiled
Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Charles River Laboratories, Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc.
Key Questions Answered in this Report:
- How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
- Service (gene synthesis service, molecular biology service, custom cloning service, and other service)
- Gene Type (standard gene, complex gene, and other gene type)
- Application (gene synthesis, gene expression, vaccine research, gene therapy, and other)
- End User (academic and research institutions, clinical laboratories, pharmaceutical and biotechnology companies, and other end user)
- Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
- What are the major market drivers, challenges, and opportunities in the global gene cloning services market?
- What are the underlying structures resulting in the emerging trends within the global gene cloning services market?
- How is each segment of the global gene cloning services market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
- What are the key developmental strategies implemented by the major players to sustain in the competitive market?
- What are the key regulatory implications in developed and developing regions for the gene cloning services market?
- Who are the leading players with significant offerings to the global gene cloning services market? What is the current market dominance for each of these leading players?
- What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which gene cloning service gene type is anticipated to have the most promising growth?
- What are the key applications in the global gene cloning services market? What are the major segments of these applications? What services are dominating these application segments?
- What are the major services that are employed in the global gene cloning services market? Which is the dominating service?
- Who are the primary end users of the global gene cloning services market? Which is the fastest-growing end-user segment in the global gene cloning services market?
- Who are the key manufacturers in the global gene cloning services market, and what are their contributions? Also, what is the growth potential of each major gene cloning services manufacturer?
- What is the scope of the global gene cloning services market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which gene cloning service application and end user dominate these regions?
- What are the emerging trends in the global gene cloning services market? How are these trends revolutionizing the diagnostic procedure?
- Which companies are anticipated to be highly disruptive in the future and why?
- What are the regulatory procedures that are required to unify the approval process for emerging gene cloning services? How will these enhance the reimbursement scenario?
- What are the gaps in regularizing optimum gene cloning services adoption in regular healthcare routines? How can these gaps be tackled?
Market Overview
Gene cloning is an essential part of medical decision-making and aid in acquiring information for a wide range of treatment dissemination, accentuating its criticality in healthcare. Gene cloning has a critical role in the precision medicine approach, as it confirms the safe and effective application of targeted therapeutics.
The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.
Factors fueling the growth of the market include a favorable funding scenario for gene synthesis and cloning services, technological advancement in cloning and subcloning services, and a rise in synergistic activities in the market. Despite rapid advancement in the industry, several key issues need to be addressed to facilitate future growth. Complications associated with large-scale production of cloning vectors and lower transfection efficiency are hampering market growth. Further, some opportunities, such as the rise in demand for gene and cloning services, the limitation of vectors or plasmids, and the development of new economic technologies and services, provide growth to the market.
Within the research report, the market has been segmented on the basis of service, gene type, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the prevalence of infectious diseases and various types of cancer on the regional level has created a buzz among companies to invest in advanced technologies such as gene cloning services.
Based on region, Asia-Pacific holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.
Table of Contents
1 Markets
- 1.1 Product Definition
- 1.2 Inclusion and Exclusion
2 Scope of the Study
- 2.1 Key Questions Answered in the Report
3 Research Methodology
- 3.1 Data Source
- 3.1.1 Primary Data Source
- 3.1.1.1 Primary Research Methodology
- 3.1.2 Secondary Data Sources
- 3.2 Market Estimation Model
- 3.2.1 Criteria for Company Profiling
4 Market Overview
- 4.1 Emerging Applications of Gene Cloning Service
- 4.2 Addressable Market Size and Growth Potential
- 4.3 COVID-19 Impact on Global Gene Cloning Services Market
- 4.3.1 Impact on Market Size
5 Competitive Landscape
- 5.1 Corporate Strategies
- 5.1.1 Synergistic Activities
- 5.1.2 Acquisitions
- 5.1.3 Business Expansion Activities
- 5.2 Business Strategies
- 5.3 Market Share Analysis (by Company)
- 5.4 Growth-Share Analysis (by Company)
6 Industry Analysis
- 6.1 Legal Requirements and Framework in the U.S.
- 6.1.1 FDA Regulations
- 6.1.2 Legal Requirements and Framework in Europe
- 6.1.2.1 U.K.
- 6.1.2.2 Germany
- 6.1.3 Legal Requirements and Framework in Asia-Pacific
- 6.1.4 Japan
- 6.1.4.1 Pharmaceuticals and Medical Devices Agency (PMDA)
7 Market Dynamics
- 7.1 Overview
- 7.2 Impact Analysis
- 7.3 Market Drivers
- 7.3.1 Favorable Funding Scenario for Gene Synthesis and Cloning Services
- 7.3.2 Technological Advancement in Cloning and Sub Cloning Services
- 7.3.3 Rise in Synergistic Activities in Market
- 7.4 Market Restraints
- 7.4.1 Complications Associated with Large-Scale Production of Cloning Vectors
- 7.4.2 Lower Transfection Efficiency
- 7.5 Market Opportunities
- 7.5.1 Rise in Demand for Gene and Cloning Services
- 7.5.2 Limitation of Vectors or Plasmid
- 7.5.3 Development of New Economical Technologies and Services
8 Global Gene Cloning Services Market, by Service, $Million, 2020-2031
- 8.1 Overview
- 8.2 Gene Synthesis Service
- 8.3 Molecular Biology Service
- 8.3.1 PCR Cloning and Sub Cloning Service
- 8.3.2 Site-Directed Mutagenesis
- 8.3.3 Other Service
- 8.4 Custom Cloning Service
- 8.5 Other Service
9 Global Gene Cloning Services Market, by Gene Type, $Million, 2020-2031
- 9.1 Overview
- 9.2 Stranded Gene
- 9.3 Complex Gene
- 9.4 Other Gene Type
10 Global Gene Cloning Services Market, by Application, $Million, 2020-2031
- 10.1 Overview
- 10.1.1 Gene Synthesis
- 10.1.2 Gene Expression
- 10.1.3 Gene Therapy
- 10.1.4 Vaccine Research
- 10.1.5 Other
11 Global Gene Cloning Services Market, by End User, $Million, 2020-2031
- 11.1 Overview
- 11.1.1 Academic and Research Institutions
- 11.1.2 Clinical Laboratories
- 11.1.3 Pharmaceutical and Biotechnology Companies
- 11.1.4 Other End User
12 Global Gene Cloning Services Market, by Region, $Million, 2020-2031
- 12.1 Overview
- 12.2 North America
- 12.2.1 North America Gene Cloning Services Market (Service)
- 12.2.1.1 North America Gene Synthesis Service Market
- 12.2.1.2 North America Molecular Biology Service
- 12.2.1.3 North America Custom Cloning Service Market
- 12.2.1.4 North America Other Service Market
- 12.2.2 U.S.
- 12.2.3 Canada
- 12.3 Europe
- 12.3.1 Europe Gene Cloning Services Market (Service)
- 12.3.1.1 Europe Gene Synthesis Service Market
- 12.3.1.2 Europe Molecular Biology Service Market
- 12.3.1.3 Europe Custom Cloning Service Market
- 12.3.1.4 Europe Other Service Market
- 12.3.2 Germany
- 12.3.3 U.K.
- 12.3.4 France
- 12.3.5 Italy
- 12.3.6 Spain
- 12.3.7 Switzerland
- 12.3.8 Rest-of-Europe
- 12.4 Asia-Pacific
- 12.4.1 Asia-Pacific Gene Cloning Services Market (Service)
- 12.4.1.1 Asia-Pacific Gene Synthesis Service Market
- 12.4.1.2 Asia-Pacific Molecular Biology Service Market
- 12.4.1.3 Asia-Pacific Custom Cloning Service Market
- 12.4.1.4 Asia-Pacific Other Service Market
- 12.4.2 China
- 12.4.3 India
- 12.4.4 Japan
- 12.4.5 Australia
- 12.4.6 South Korea
- 12.4.7 Rest-of-Asia-Pacific
- 12.5 Latin America (LATAM)
- 12.5.1 Latin America (LATAM) Gene Cloning Services Market (Service)
- 12.5.1.1 Latin America (LATAM) Gene Synthesis Service Market
- 12.5.1.2 Latin America (LATAM) Molecular Biology Service Market
- 12.5.1.3 Latin America (LATAM) Custom Cloning Service Market
- 12.5.1.4 Latin America (LATAM) Other Service Market
- 12.5.2 Brazil
- 12.5.3 Mexico
- 12.5.4 Rest-of-Latin America
- 12.6 Rest-of-the-World (RoW)
- 12.6.1 Rest-of-the-World (RoW) Gene Cloning Services Market (Service)
- 12.6.1.1 Rest-of-the-World (RoW) Gene Synthesis Service Market
- 12.6.1.2 Rest-of-the-World (RoW) Molecular Biology Service Market
- 12.6.1.3 Rest-of-the-World (RoW) Custom Cloning Service Market
- 12.6.1.4 Rest-of-the-World (RoW) Other Service Market
13 Company Profiles
- 13.1 Overview
- 13.2 Thermo Fisher Scientific Inc.
- 13.2.1 Company Overview
- 13.2.2 Role of Thermo Fisher Scientific Inc. in the Global Gene Cloning Services Market
- 13.2.3 Key Customers of the Company
- 13.2.4 Key Competitors of the Company
- 13.2.5 Financials
- 13.2.6 Key Insights about the Financial Health of the Company
- 13.2.7 SWOT Analysis
- 13.3 Eurofins Scientific
- 13.3.1 Company Overview
- 13.3.2 Role of Eurofins Scientific in the Global Gene Cloning Services Market
- 13.3.3 Key Customers of the Company
- 13.3.4 Key Competitors of the Company
- 13.3.5 Financials
- 13.3.6 SWOT Analysis
- 13.4 GenScript
- 13.4.1 Company Overview
- 13.4.2 Role of GenScript in the Global Gene Cloning Services Market
- 13.4.3 Key Customers of the Company
- 13.4.4 Key Competitors of the Company
- 13.4.5 Financials
- 13.4.6 Key Insights about the Financial Health of the Company
- 13.4.7 SWOT Analysis
- 13.5 Merck KGaA
- 13.5.1 Company Overview
- 13.5.2 Role of Merck KGaA in the Global Gene Cloning Services Market
- 13.5.3 Key Customers of the Company
- 13.5.4 Key Competitors of the Company
- 13.5.5 Financials
- 13.5.6 Key Insights about the Financial Health of the Company
- 13.5.7 SWOT Analysis
- 13.6 Takara Bio Inc.
- 13.6.1 Company Overview
- 13.6.2 Role of Takara Bio Inc. in the Global Gene Cloning Services Market
- 13.6.3 Key Customers of the Company
- 13.6.4 Key Competitors of the Company
- 13.6.5 Financials
- 13.6.6 Key Insights about the Financial Health of the Company
- 13.6.7 SWOT Analysis
- 13.7 Charles River Laboratories
- 13.7.1 Company Overview
- 13.7.2 Role of Charles River Laboratories in the Global Gene Cloning Services Market
- 13.7.3 Key Customers of the Company
- 13.7.4 Key Competitors of the Company
- 13.7.5 Financials
- 13.7.6 SWOT Analysis
- 13.8 Lonza
- 13.8.1 Company Overview
- 13.8.2 Role of Lonza in the Global Gene Cloning Services Market
- 13.8.3 Key Customers of the Company
- 13.8.4 Key Competitors of the Company
- 13.8.5 Financials
- 13.8.6 SWOT Analysis
- 13.9 Sartorius AG
- 13.9.1 Company Overview
- 13.9.2 Role of Sartorius AG in the Global Gene Cloning Services Market
- 13.9.3 Key Customers of the Company
- 13.9.4 Key Competitors of the Company
- 13.9.5 Financials
- 13.9.6 SWOT Analysis
- 13.1 Creative Biogene
- 13.10.1 Company Overview
- 13.10.2 Role of Creative Biogene in the Global Gene Cloning Services Market
- 13.10.3 Key Customers of the Company
- 13.10.4 Key Competitors of the Company
- 13.10.5 SWOT Analysis
- 13.11 Cellecta, Inc.
- 13.11.1 Company Overview
- 13.11.2 Role of Cellecta, Inc., in the Global Gene Cloning Services Market
- 13.11.3 Key Customers of the Company
- 13.11.4 Key Competitors of the Company
- 13.11.5 SWOT Analysis
- 13.12 Synbio Technologies
- 13.12.1 Company Overview
- 13.12.2 Role of Synbio Technologies in the Global Gene Cloning Services Market
- 13.12.3 Key Customers of the Company
- 13.12.4 Key Competitors of the Company
- 13.12.5 SWOT Analysis
- 13.13 TransGen Biotech Co., Ltd.
- 13.13.1 Company Overview
- 13.13.2 Role of TransGen Biotech Co., Ltd. in the Global Gene Cloning Services Market
- 13.13.3 Key Customers of the Company
- 13.13.4 Key Competitors of the Company
- 13.13.5 SWOT Analysis
- 13.14 Dobuss (Canvax)
- 13.14.1 Company Overview
- 13.14.2 Role of Dobuss (Canvax) in the Global Gene Cloning Services Market.
- 13.14.3 Key Customers of the Company
- 13.14.4 Key Competitors of the Company
- 13.14.5 SWOT Analysis
- 13.15 Azenta US, Inc.
- 13.15.1 Company Overview
- 13.15.2 Role of Azenta US, Inc. in the Global Gene Cloning Services Market
- 13.15.3 Key Customers of the Company
- 13.15.4 Key Competitors of the Company
- 13.15.5 Financials
- 13.15.6 Key Insights about the Financial Health of the Company
- 13.15.7 SWOT Analysis
- 13.16 Macrogen, Inc.
- 13.16.1 Company Overview
- 13.16.2 Role of Macrogen, Inc. in the Global Gene Cloning Services Market
- 13.16.3 Key Customers of the Company
- 13.16.4 Key Competitors of the Company
- 13.16.5 SWOT Analysis
- 13.17 Codex DNA, Inc.
- 13.17.1 Company Overview
- 13.17.2 Role of Codex DNA, Inc. in the Global Gene Cloning Services Market
- 13.17.3 Key Customers of the Company
- 13.17.4 Key Competitors of the Company
- 13.17.5 SWOT Analysis